Analystreport

Radius Health Inc (NASDAQ: RDUS) had its "buy" rating re-affirmed by analysts at Morgan Stanley. They now have a $59.00 price target on the stock.

Radius Recycling, Inc. - Class A  (RDUS) 
Last radius recycling, inc. - class a earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.radiuspharm.com